It is anticipated that this will improve insulin sensitivity and reduce fatty liver disease, hyperglycaemia and salt-sensitive hypertension
This new medicine can really help people lose weight, which could change how we treat obesity
Patients with personal or family history of medullary thyroid carcinoma should avoid GLP-1 therapy entirely
Serious Risks There are some rare but potentially dangerous side effects
Within days to weeks of stopping treatment, patients generally experience return of appetite to pre-treatment levels, faster gastric emptying, and loss of the medication's effects on satiety signaling
For context, if you are following a semaglutide 5mg/mL dosage chart but your product is actually 7% pure, the math breaks down completely